Elexacaftor/tezacaftor/ivacaftor use is linked to long-term decreases in chronic respiratory therapies in patients with cystic fibrosis.

Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...

Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.

(HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of uncomplicated urogenital gonorrhea, according to a study published online Dec. 11 in The Lancet.

A novel oral antibiotic zoliflodacin is as effective as ceftriaxone plus azithromycin in treating uncomplicated urogenital ...

India and large parts of the world are now facing a rising antibiotic resistance or antimicrobial resistance (AMR) crisis. Apart from international bodies like the World Health Organization (WHO) and ...

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several changes to the way the antibiotic azithromycin is used in the EU, including the removal of certain indications.

Please provide your email address to receive an email when new articles are posted on . Azithromycin for 5 days was studied against placebo. Futility analyses stopped this trial early. Being negative ...

Azithromycin was effective for the treatment for women with Ureaplasma urealyticum, showing a similar therapeutic effect to that of doxycycline. Results of a systematic review and meta-analysis ...

MONDAY, April 21, 2025 (HealthDay News) -- For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin, according to ...